Neuronetics Inc
NASDAQ:STIM
Neuronetics Inc
NASDAQ:STIM
Price:
3.555 USD
5.49%
Market Closed
Updated:
May 2, 2024
Neuronetics Inc
Cash from Operating Activities
|
Neuronetics Inc
Cash from Operating Activities Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Neuronetics Inc
NASDAQ:STIM
|
Cash from Operating Activities
-$32m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Operating Activities
$3.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Operating Activities
$2.5B
|
CAGR 3-Years
18%
|
CAGR 5-Years
52%
|
CAGR 10-Years
8%
|
|
|
Stryker Corp
NYSE:SYK
|
Cash from Operating Activities
$3.7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Operating Activities
$7.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Operating Activities
$1.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
See Also
What is Neuronetics Inc's Cash from Operating Activities?
Cash from Operating Activities
-32m
USD
-32m
USD
Based on the financial report for Dec 31, 2023, Neuronetics Inc's Cash from Operating Activities amounts to -32m USD.
What is Neuronetics Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-9%
-9%
Over the last year, the Cash from Operating Activities growth was -4%. The average annual Cash from Operating Activities growth rates for Neuronetics Inc have been -4% over the past three years , -9% over the past five years .
You don't have any saved screeners yet
